Clinical Development in Advanced Therapies

Connecting the leaders moving advanced therapies from early development to patient access.

Clinical development is the process of advancing a therapy from laboratory research through clinical trials and towards regulatory approval and commercial adoption. Within cell therapy, gene therapy, regenerative medicine and other advanced therapies, clinical development involves far more than trial execution alone. Success depends on regulatory strategy, manufacturing readiness, patient recruitment, supply chain design, investment, reimbursement planning and long-term patient access.

Navigating Clinical Development in Advanced TherapieS

As the advanced therapies sector matures, organisations face increasing pressure to demonstrate clinical efficacy, generate meaningful evidence, scale manufacturing and prepare for commercial reality. These challenges require collaboration across biotech, pharma, academia, healthcare providers, investors, regulators, manufacturers and technology partners.

Phacilitate supports the global advanced therapies community through industry events, expert content, market insights and thought leadership. Across North America, Europe and the Middle East, we bring together the people shaping the future of clinical development, helping organisations share knowledge, build partnerships and accelerate the delivery of life-changing therapies to patients.

Attend an Advanced Therapies Event with Phacilitate

Each gathering brings together the brightest minds working in cell and gene innovation, from discovery scientists and manufacturers to investors, regulators, and patient advocates.

Advanced Therapies Week

09 - 12 February 2026 Convention Center, San Diego, USA Often called t ...

Week

09 - 12 February 2026
Convention Center, San Diego, USA

Often called the “Super Bowl” of advanced therapies, this flagship event attracts more than 2,000 global professionals. Explore breakthroughs in CAR-T, stem-cell and regenerative technologies, alongside investors and deal-makers driving the field forward.

Find Our More

Advanced Therapies Europe

07–09 September 2026 Hotel Arts, Barcelona, Spain Europe’s most focuse ...

Europe

07–09 September 2026
Hotel Arts, Barcelona, Spain

Europe’s most focused meeting for senior biotech and biopharma leaders. Expect in-depth debate on manufacturing scalability, regulatory harmonisation, automation, and cross-border collaboration in advanced therapies.

Find Out More

Advanced Therapies World

10-11 November 2026 Four Seasons Hotel Riyadh, Saudi Arabia Launching ...

World

10-11 November 2026
Four Seasons Hotel Riyadh, Saudi Arabia

Launching 2026, this event opens new pathways for cell-based innovation across the Middle East. Meet emerging biotech leaders, investors, and regulators building the region’s fast-growing life-sciences ecosystem.

 

Find Out More

Leading Voices in CGT

Our events feature the industry’s foremost experts, from pioneering biotech founders to global regulators. Past speakers include leaders from FDA, EMA, Novartis, Spark Therapeutics, Bluebird Bio and more.


See All Speakers

World Class Exhibitors

Meet the organisations driving innovation across the gene and cell therapy landscape.
Previous exhibitors include Thermo Fisher Scientific, Cytiva, Lonza, MilliporeSigma and other global leaders.

 

See All Exhibitors

Why Attend a Phacilitate Cell Therapy Event?

Our conferences are designed to support professionals across every stage of therapeutic development:

  • Gain insights from global regulators, CDMOs, and pioneers shaping the policy landscape.

  • Learn from real-world case studies in manufacturing, logistics, and clinical application.

  • Join collaborative roundtables on automation, analytics, and scale-up.

  • Connect with strategic partners, investors, and service providers driving progress.

Have a Question?

The conferences explore every stage of the Gene and Cell Therapy value chain, from early research to commercial delivery. Sessions cover cell-based therapies, advanced manufacturing, automation, analytics, regulatory hurdles, patient access, and global market expansion. Attendees gain practical insights into how scientific and operational teams can accelerate safe, scalable product development.

You’ll meet industry leaders across biotech, pharma, and academia, along with cell engineers, clinicians, CDMOs, CROs, investors, and patient advocates. The audience includes both decision-makers and early-career scientists looking to expand their expertise and professional networks.

Phacilitate events are designed for high value connection. From structured one-to-one meetings to informal lounges and evening receptions, you’ll build relationships that drive collaboration and innovation. Dedicated sessions help bridge the gap between established industry leaders and emerging cell engineers.

Yes. Dedicated tracks and mentoring sessions support emerging biotechs with guidance on trial readiness, product development, manufacturing partnerships, and investment strategy. You’ll also find investors and commercial partners keen to meet innovators across the Gene and Cell Therapy landscape.

Exhibitors span the full value chain, from cell sourcing and culture technologies to automation, logistics, and quality control. They include partners supporting discovery, pre-clinical, clinical, and commercial phases of cell-based therapies.

Yes. While each congress brings both communities together, dedicated sessions ensure targeted learning and discussion for specialists in either discipline, whether your focus is regulatory reform, next-gen vectors, or engineered cell platforms.

Beyond scientific sessions, attendees can join workshops on career development, leadership, and cross-functional collaboration. Early-career scientists gain exposure to industry leaders, learn from case studies, and connect with mentors advancing innovation across the Gene and Cell Therapy sector.

Yes. Events such as Advanced Therapies Europe offer CPD accreditation, supporting your ongoing professional growth in manufacturing, regulatory strategy, and innovation.

Registration typically opens several months before each event. You can apply to attend, speak, or exhibit via the event pages.


 

Award-winning events which focus on the science 
and commercialization of advanced therapies

Other core topics

Gene Therapy

Discover innovations in cell-based treatments, manufacturing, and delivery, from pioneering research to clinical and commercial application. Find out more

TBC.

Learn how cell and gene therapies are transforming cancer care, from breakthrough trials to scalable, patient-ready solutions. Find out more